Pure Global AI
Disease / condition

Brain and Central Nervous System Tumors clinical trials

Free access to 288 studies10+ countriesUpdated daily4 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
288
Total trials
10+
Countries
10+
Sponsors
4
Recruiting
By phase
Phase 2120
Phase 180
Early Phase 140
Phase 328
N/A19
By status
Completed215
Unknown32
Terminated19
Withdrawn12
Recruiting4
Top countries
United States of America190
Canada,United States of America15
United Kingdom9
Ireland,United Kingdom8
Canada5
Top sponsors
Sidney Kimmel Comp...30
Duke University23
National Cancer In...21
European Organisat...21
Jonsson Comprehens...15
Recent trials
Latest clinical trials for Brain and Central Nervous System Tumors
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Alliance for Clinical Trials i... · United States of America;United States of America;United States of America;United States of America;
ANZCTR12620000402943
Phase
Phase 3
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
Sidney Kimmel Comprehensive Ca... · United States of America
NCT03965494Recruiting
Phase
Early Phase 1
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
St. Jude Children's Research H... · United States of America
NCT03696355Not yet recr...
Phase
Phase 1
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene USA, Inc. · Netherlands,Switzerland,United States of America
NCT03150862Completed
Phase
Early Phase 1
Cooperative Multicenter Study for Children and Adolescents With Low Grade Glioma
Societe Internationale d'Oncol... · Austria,Belgium,Croatia,Denmark,France,Germany,Italy,Norway,Poland,Portugal,Switzerland,United Kingd
DRKS00003771Recruiting
Phase
Not Applicable
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Children's Oncology Group
NCT01585389Completed
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Sidney Kimmel Comprehensive Ca... · United States of America
NCT01480050Completed
Phase
Phase 1
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
Cancer Research UK · United Kingdom
NCT01390571Completed
Phase
Phase 1
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
Cancer Research UK · United Kingdom
NCT01233492Terminated
Phase
Phase 1
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
Pediatric Brain Tumor Consorti... · United States of America
NCT01233479Withdrawn
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Cancer Research UK · United Kingdom
NCT01222221Completed
Phase
Phase 1
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Pediatric Brain Tumor Consorti... · United States of America
NCT01158300Completed
Phase
Phase 1
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Radiation Therapy Oncology Gro... · Canada,Israel,United States of America
NCT01062399Completed
Phase
Early Phase 1
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Radiation Therapy Oncology Gro... · United States of America
NCT01026493Completed
Phase
Early Phase 1
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
European Organisation for Rese... · Belgium,France,Germany,Italy,Netherlands,Spain,Switzerland,United Kingdom
NCT01019434Completed
Phase
Phase 2
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Jonsson Comprehensive Cancer C... · United States of America
NCT01013285Completed
Phase
Phase 2
Study of Blood and Cheek Cell Samples From Patients With Glioma
University of California, San ... · United States of America
NCT01009307Completed
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Alliance for Clinical Trials i... · United States of America
NCT01004523Completed
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Alliance for Clinical Trials i... · United States of America
NCT01004887Completed
Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Jonsson Comprehensive Cancer C... · United States of America
NCT00998010Completed
Phase
Phase 2
About this profile

Access comprehensive clinical trial information for Brain and Central Nervous System Tumors through Pure Global AI's free database. This collection includes 288 clinical trials across multiple phases including Phase 2, Phase 1, Early Phase 1. Currently, 4 trials are actively recruiting participants.

Research for Brain and Central Nervous System Tumors is being conducted in United States of America, Canada,United States of America, United Kingdom and 7+ other countries. Leading sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Duke University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 288 clinical trials studying Brain and Central Nervous System Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Duke University, National Cancer Institute (NCI), among others.